Crizotinib/lorlatinibLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1941卷 / 1期

关键词：

D O I：

10.1007/s40278-023-32418-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：155 / 155

相关论文

共 50 条

[21] Crizotinib/rifampicin interactionDecrease in crizotinib plasma concentration: case report
Reactions Weekly, 2019, 1780 (1) : 120 - 120
[22] CrizotinibAcquired resistance to crizotinib: case report
Reactions Weekly, 2019, 1762 (1) : 125 - 125
[23] Crizotinib/pemetrexedVarious toxicities: case report
Reactions Weekly, 2016, 1616 (1) : 53 - 53
[24] Crizotinib/lorlatinibPneumonitis and no response: case report
Reactions Weekly, 2021, 1852 (1) : 146 - 146
[25] Crizotinib/osimertinibIntermittent fatigue: case report
Reactions Weekly, 2017, 1662 (1) : 111 - 111
[26] Crizotinib/lorlatinibDrug resistance: case report
Reactions Weekly, 2022, 1928 (1) : 145 - 145
[27] CrizotinibDevelopment of crizotinib resistance: case report
Reactions Weekly, 2018, 1714 (1) : 130 - 130
[28] Crizotinib/gefitinibDevelopment of resistance: case report
Reactions Weekly, 2017, 1676 (1) : 107 - 107
[29] CrizotinibAcquired resistance to crizotinib: case report
Reactions Weekly, 2019, 1750 (1) : 94 - 94
[30] Crizotinib/lorlatinibVarious toxicities: case report
Reactions Weekly, 2021, 1860 (1) : 133 - 133

← 1 2 3 4 5 →